FDA grants priority review to omalizumab for food allergies
If approved, monoclonal antibody omalizumab would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposure.
List view / Grid view
If approved, monoclonal antibody omalizumab would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposure.
Explore the internal workings of two of the most common drug delivery devices - the powder asthma inhaler and the EpiPen®.
The continuous-flow microfluidic device allows scientists to assess crystalline API growth rates, shapes and structures to more quickly identify the best conditions for drug manufacturing.
A study has found that paracetamol use in infancy, as well as genetic factors, may increase the likelihood of developing asthma...
Researchers aim to develop a new immunotherapy that could alter the immune reactions to food. The result: Extended relief from peanut allergies...